Tentan AG   Report issue

For profit Phase 4
Founded: Itingen Switzerland (1988)
Status: No NME R&D (1988)

Organization Overview

First Clinical Trial
2014
NCT02042287
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

glycogen (1 trial)

lactic acid (1 trial)

metronidazole (flagyl) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Vaginal Diseases (Phase 4)

Vaginosis, Bacterial (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3